ReachBio Research Labs Offers New NK (V158+) Cells Optimized for ADCC Assays online
SEATTLE, May 9, 2017 — ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is now offering sourced, enriched and tested primary natural killer (V158+) cells from normal and healthy donors to facilitate better antibody research through ADCC assays. One of the important mechanisms by which antibodies... Read more